Canada markets close in 5 hours 24 minutes

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6600+0.4100 (+18.22%)
As of 10:23AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
5,118
5,118
10,763
4,839
1,292
Selling General and Administrative
11,822
11,822
11,082
7,186
2,904
Total Operating Expenses
16,940
16,940
21,845
12,026
4,196
Operating Income or Loss
-16,940
-16,940
-21,845
-12,025
-4,196
Interest Expense
-
-
0
92.822
147.934
Total Other Income/Expenses Net
1,750
1,750
194.413
62.259
4
Income Before Tax
-15,190
-15,190
-21,651
-12,056
-4,340
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-15,190
-15,190
-21,651
-12,056
-4,340
Net Income
-15,190
-15,190
-21,651
-12,056
-4,340
Net Income available to common shareholders
-15,190
-15,190
-21,651
-12,056
-4,340
Basic EPS
-1.17
-
-184.90
-18.10
-9.62
Diluted EPS
-1.17
-
-184.90
-18.10
-9.62
Basic Average Shares
11,714
-
117.102
667.727
450.879
Diluted Average Shares
11,714
-
117.102
667.727
450.879